The American Heart Association, American Academy of Pediatrics, American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine have recently introduced a new framework for cardiovascular care in girls and women.
Northwestern Medicine patient Sarah Fishbune.
(Source: Northwestern University)
Chicago/USA – For the first time, four leading medical societies have banded together to create a shared framework for assessing and improving women’s heart health across the lifespan, starting in childhood. The American Heart Association (AHA), American Academy of Pediatrics, American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine have recently released a three-part publication introducing a new framework for cardiovascular care in girls and women. Northwestern University cardiology experts Dr. Sadiya Khan and Dr. Amanda Marma Perak are chair and vice chair, respectively, of the collaborative science advisory group for the new shared framework. Northwestern internal medicine expert Dr. Natalie Cameron is a member of the writing group.
Three manuscripts, recently published simultaneously in the AHA’s flagship journal Circulation, outline the framework. Two papers establish “Female Life Stages” with four stages to help clinicians identify cardiovascular risks earlier and intervene sooner. The third proposes a national network of comprehensive cardiovascular care centers for women built around four pillars: interdisciplinary care, professional training, research and community engagement.
“Each of these four societies has been addressing women’s heart health but it has been siloed across specialties, which leads to fragmented care for women,” said Khan, associate professor of preventive medicine at Northwestern University Feinberg School of Medicine and a Northwestern Medicine cardiologist. “It’s like we’ve all been playing different sports and now we’re trying to create a new sport with a singular playbook.”
Cardiovascular disease remains the leading cause of death among U.S. women, yet progress in reducing those deaths has largely stalled over the past two decades.
“Heart health begins long before adulthood,” said Perak, associate professor of pediatrics and preventive medicine at Feinberg and a pediatric cardiologist at Ann & Robert H. Lurie Children’s Hospital of Chicago. “As pediatric clinicians, we have the opportunity to help every girl start strong and ensure that what we learn about her health follows her as she grows.”
Pregnancy complications, including preeclampsia, gestational diabetes and preterm birth, are already recognized as female-specific cardiovascular risk enhancers. In addition, conditions often viewed primarily through a reproductive-health lens, such as polycystic ovary syndrome (now known as polyendocrine metabolic ovarian syndrome), may serve as early indicators of future cardiovascular risk, Khan said.
“This work was a truly collaborative, multidisciplinary effort, reflecting the interdisciplinary nature of cardiovascular health promotion in women and the importance of partnerships across specialties,” said Cameron, assistant professor of general internal medicine and preventive medicine at Feinberg and a Northwestern Medicine physician.
Sex matters in personalized medicine
The new compendium arrives amid growing attention on women’s health and longstanding gaps in cardiovascular care and research for women, who make up half the population, Khan said. The framework provides clinicians with evidence-based guidance for identifying cardiovascular risk earlier and delivering more personalized care to girls and women throughout life.
“As we continue to advance a personalized approach to health, sex matters,” Khan said. “There are clear differences by sex and gender that influence cardiovascular health. Both must be accounted for.”
A first-of-its-kind Female Life Stage framework
The Female Life Stage framework gives clinicians across specialties a common way to identify, monitor and address cardiovascular risk as girls and women move through major hormonal transitions. Each of the four stages is anchored in key hormonal transitions unique to female development:
Date: 08.12.2025
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.
Stage 1 perimenarche: The years around a girl's first menstrual period, as hormone cycles mature. Approximate age range is 8 to 15.
Stage 2 ovarian cycling: Regular ovulatory and hormone cycles are established and when pregnancy may occur. Approximate age range is 15 to 44 years old.
Stage 3 perimenopause: The transition to variable cycle length, skipped cycles and hormone changes. Approximate age range is 45 to 51 years old.
Stage 4 postmenopause: The years that begin after menopause or 12 months after the final menstrual period. Approximate age is 51 years and older.
The time before, during and after pregnancy is highlighted as a biological “stress test” that can identify cardiovascular risks that may have been previously unrecognized, according to the new framework.
“Women’s health is an everyone issue,” Khan said. “Health starts very early in life and those foundational years matter.”